局限期小细胞肺癌预防性脑照射后脑转移相关危险因素分析被引量：1

Analysis of risk factors associated with brain metastasis of limited small cell lung cancer after prophylactic cranial irradiation

原文传递

导出

摘要小细胞肺癌具有易复发和转移的生物学特点,脑是小细胞肺癌肺外转移的好发部位。局限期小细胞肺癌患者行预防性脑照射(PCI)能够有效降低脑转移的发生率,延长总生存期。但是在PCI后仍有近1/3的患者发生脑转移。本文对PCI后脑转移的危险因素进行综述,目的在于判断何种局限期小细胞肺癌亚组患者能够从PCI中获益,从而为PCI的临床应用提供参考。 Small cell lung cancer(SCLC)has the biological characteristics of high recurrence and metastasis.The brain is the common site of SCLC extrapulmonary metastasis.Prophylactic cranial irradiation(PCI)can effectively reduce the incidence of brain metastasis and prolong the overall survival of patients with limited SCLC.Nevertheless,nearly one third of patients develop brain metastases after PCI.This article reviews the risk factors of brain metastasis after PCI,aiming to determine which subgroup of patients with limited SCLC can benefit from PCI and provide reference for the clinical application of PCI.

作者李明旭胡松柳 Li Mingxu;Hu Songliu(Department of Radiation Oncology,Harbin Medical University Cancer Hospital,Harbin 150081,China)

机构地区哈尔滨医科大学附属肿瘤医院放疗科

出处《中华放射肿瘤学杂志》 CSCD 北大核心 2022年第4期395-399,共5页 Chinese Journal of Radiation Oncology

基金国家癌症中心攀登基金(NCC201808B015) 中国医疗手牵手工程委员会-北京医学奖励基金会基金(YXJL-2020-0961-0159)。

关键词癌小细胞肺预防性脑照射脑转移危险因素 Neoplasm,small cell lung Prophylactic cranial irradiation Brain metastasis Risk factor

分类号 R734.2 [医药卫生—肿瘤] R730.55 [医药卫生—肿瘤]

引文网络
相关文献

参考文献6

1刘璇,周宗玫,肖泽芬,冯勤付,陈东福,吕纪马,梁军,毕楠,王鑫,邓垒,张涛,王文卿,王小震,惠周光,王绿化.现代诊疗技术下脑预防照射在局限期小细胞肺癌中的疗效分析[J].中华放射肿瘤学杂志,2021,30(2):114-119. 被引量：2
2霍东杰,陆艳荣,王海峰,张玲,阿不力克木江.阿地力,李月,张瑾熔.预防性全脑照射及其不同介入时机对局限期小细胞肺癌预后的影响[J].天津医药,2017,45(12):1261-1265. 被引量：5
3裘国勤,周霞,包婺安,张丹红,杜向慧,季永领,程蕾,陈影.局限期SCLC预防性脑照射后脑转移的危险因素分析[J].中华放射肿瘤学杂志,2016,25(10):1062-1065. 被引量：3
4陈维领,李鑫,陈杼君,刘攀,唐春兰,宫亮.伊立替康联合铂类一线化疗对小细胞肺癌脑转移的影响[J].第三军医大学学报,2020,42(5):487-492. 被引量：6
5韩宝惠,林嘉欣.预防性全脑放疗在手术完全切除小细胞肺癌的应用[J].循证医学,2017,17(4):216-217. 被引量：9
6曾海燕,李睿,孙新东,谢鹏,孟雪,范秉杰,李万龙,袁双虎.局限期小细胞肺癌患者预防性脑照射后脑转移的关联分析:双中心研究[J].山东大学学报（医学版）,2017,55(7):61-66. 被引量：8

二级参考文献24

1Takada M,Fukuoka M,Kawahara M,et al. Phase Ⅲ study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer:results of the Japan Clinical Oncology Group Study 9104[J].J Clin Oncol,2002,20(14):3054-3060.DOI:10.1200/JCO.2002.12.071.
2Komaki R,Cox JD,Whitson W.Risk of brain metastasis from small cell carcinoma of the lung related to length of survival and prophylactic irradiation[J].Cancer Treat Rep,1981,65(9-10):811-814.
3Aupérin A,Arriagada R,Pignon JP,et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic cranial irradiation overview collaborative group[J].New Engl J Med,1999,341(7):476-484.DOI:10.1056/NEJM199908123410703.
4Le Péchoux C,Dunant A,Senan S,et al. Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01,EORTC 22003-08004,RTOG 0212,and IFCT 99-01):a randomised clinical trial[J].Lancet Oncol,2009,10(5):467-474.DOI:10.1016/S1470-2045(09)70101-9.
5Baas P,Belderbos JS,Senan S,et al. Concurrent chemotherapy (carboplatin,paclitaxel,etoposide) and involved-field radiotherapy in limited stage small cell lung cancer:a Dutch multicenter phase Ⅱ study[J]. Br J Cancer,2006,94(5):625-630.DOI:10.1038/sj.bjc.6602979.
6Lishner M,Feld R,Payne DG,et al. Late neurological complications after prophylactic cranial irradiation in patients with small-cell lung cancer:the Toronto experience[J]. J Clin Oncol,1990,8(2):215-221.
7Wong WW,Schild SE,Sawyer TE,et al. Analysis of outcome in patients reirradiated for brain metastases[J]. Int J Radiat Oncol Biol Phys,1996,34(3):585-590.DOI:10.1016/0360-3016(95)02156-6.
8Lo SSM,Gore EM,Bradley JD,et al. ACR Appropriateness Criteriapre-irradiation evaluation and management of brain metastases[EB/OL].[2015-01-20].https://acsearch.acr.org/docs/69384/Narrative/.
9Yamamoto M,Serizawa T,Shuto T,et al. Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901):a multi-institutional prospective observational study[J].Lancet Oncol,2014,15(4):387-395.DOI:10.1016/S1470-2045(14)70061-0.
10Seto T,Takahashi T,Yamanaka T,et al. Prophylactic cranial irradiation (PCI) has a detrimental effect on the overall survival (OS) of patients (pts) with extensive disease small cell lung cancer (ED-SCLC):results of a Japanese randomized phase Ⅲ trial[J].J Clin Oncol,2014,32(15):7503.